Results 101 to 110 of about 4,045,135 (314)
This study identifies ARHGAP5, in addition to the frequently mutated ARHGAP35, as significantly mutated in endometrial cancer. Mutations in both genes co‐occur and are associated with their correlated downregulation. Functional CRISPR studies show that both paralogs regulate similar pathways, including actin cytoskeleton organization.
Mathilde Pinault +12 more
wiley +1 more source
Background IDH and TERTp mutations serve as key molecular markers in glioma, closely associated with tumor clinical behavior, treatment response, and patient survival.
Xuan Li +5 more
doaj +1 more source
Incomplete microwave ablation (iMWA) of liver cancer triggers a biphasic progression in residual tumors. At Day 3, the microenvironment is characterized by acute inflammatory responses and extracellular matrix (ECM) remodeling. By Day 14, a profound shift occurs toward oncogenic signal transduction and immunosuppression, marked by macrophage ...
Yu Liu +9 more
wiley +1 more source
Circulating microRNA profiles distinguish nonmalignant Lynch syndrome from cancer‐associated Lynch syndrome, sporadic colorectal cancer, and healthy controls. Age‐stratified analysis reveals disease‐specific regulatory states, and a six‐miRNA panel shows concordant separation in an independent colorectal tissue cohort.
Ramadhani Salum Chambuso +5 more
wiley +1 more source
Molecular subtypes, histopathological grade and survival in a historic cohort of breast cancer patients [PDF]
Molecular subtyping of breast cancer may provide additional prognostic information regarding patient outcome. However, its clinical significance remains to be established.
Bofin, Anna M. +16 more
core +1 more source
Targeting the EpCAM‐AXL axis to overcome drug resistance in lung cancer
Lung cancer cells often evade therapy by hijacking signaling pathways. We reveal that cleaved EpCAM (sEpCAM) stabilizes the oncogenic protein AXL, driving NF‐κB and STAT3‐mediated chemoresistance. This EpCAM‐AXL axis identifies a high‐risk patient subset with poor prognosis.
Alexa Guerrero‐Alba +5 more
wiley +1 more source
Correlation between various perfusion parameters and molecular markers and subtypes.
Correlation between various perfusion parameters and molecular markers and subtypes.
Hyun-Bin Kim (3609215) +7 more
core +1 more source
The anticancer effects of ruxolitinib and calcitriol against breast cancer were reported previously. However, the effect of ruxolitinib and calcitriol combination treatment on various molecular subtypes of breast cancer remains unexplored. In this study,
Seung Taek Lim +3 more
core +1 more source
Nonfamilial breast cancer subtypes
Over the last decade, our knowledge in somatic genetic events related to breast cancer has increased -enormously. Through usage of various genome-wide molecular approaches, it has become increasingly clear that breast cancer is a vastly heterogeneous ...
Ringnér, Markus, +3 more
core +2 more sources
Advances in the molecular subtyping of gastric cancer
Despite decades of significant progress in gastric cancer research, the prognosis remains poor because of the disease's high aggressiveness. Historically, gastric cancers were classified based on histopathology and anatomical site-criteria that inadequately support precision therapy.
Chen, Jiayi, Zhang, Xijie, Zhao, Yuzhou
openaire +2 more sources

